Sotera Health Co
At today's price, Sotera Health Co (SHC) is priced for +20.5% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Sotera Health runs a regulated, high-switching-cost sterilization and testing oligopoly (Sterigenics, Nordion, Nelson Labs) that earns a roughly 24% operating margin, a moat the $2.16 book value per share badly understates. • The defining risks are leverage and litigation: about $1.92 billion of net debt at 6.7 times operating income, plus ongoing ethylene-oxide tort exposure that drove a $30.9 million settlement charge a year ago. • Watch the deleveraging path and the EO litigation, where Mar
Is SHC overvalued? See what's priced in →
286 institutional managers reported holding SHC in 13F filings for the quarter ended 2026-03-31. 47 opened new positions that quarter. Held by Vanguard Group, Sculptor Capital, BlackRock, among others. On the short side, 17.6M shares were sold short as of the 2026-06-15 count, about 6% of shares outstanding (7.1 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
SHC's share count grew 2.1% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at SHC over the trailing three years. Absence is a fact about the company, not a signal. 36 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
SHC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-05-04 | -7.5% | +20.0% |
| 2023-08-04 | -3.7% | -19.0% |
| 2023-11-02 | +1.2% | +25.5% |
| 2024-02-28 | -12.3% | -24.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
SHC's latest 8-K filings: 2026-05-22 (items 5.07); 2026-05-20 (items 1.01, 2.03, 9.01); 2026-05-13 (items 1.02, 8.01, 9.01); 2026-05-05 (items 2.02, 5.02, 9.01); 2026-03-16 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.